Laboratory Corporation of America Holdings Stock price

Equities

LH

US50540R4092

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 11:12:58 2023-10-02 am EDT Intraday chart for Laboratory Corporation of America Holdings 5-day change 1st Jan Change
197.66 USD -1.69% -5.10% -16.00%
Sales 2023 * 12,213 M Sales 2024 * 12,481 M Capitalization 17 833 M
Net income 2023 * 921 M Net income 2024 * 1,056 M EV / Sales 2023 *
1,76x
Net Debt 2023 * 3,703 M Net Debt 2024 * 3,470 M EV / Sales 2024 *
1,71x
P/E ratio 2023 *
19,8x
P/E ratio 2024 *
16,9x
Employees -
Yield 2023 *
1,45%
Yield 2024 *
1,08%
Free-Float99.73%
More Fundamentals * Assessed data
Dynamic Chart
EARNINGS: Ukrproduct outlook uncertain amid war; Microlise revenue up AN
Graves Gilbert, Circuit Clinical, and Labcorp Announce A Collaboration to Bring Clinical Trials to Patients Across South Central Kentucky CI
Adela, Inc. announced that it has received $48 million in funding from OrbiMed Advisors LLC, Deerfield Management Company, L.P. Series C, RA Capital Management, L.P., Decheng Capital LLC, Impresa Management LLC, Laboratory Corporation of America Holdings CI
BofA Securities Adjusts Price Target on Laboratory Corp of America to $230 From $238, Maintains Buy Rating MT
Laboratory Corporation of America Holdings announced that it expects to receive funding from Outcomes4me Inc. CI
All eyes on the Fed ZB
ANALYST RECOMMENDATIONS : Accenture, Air Products, Electronic Arts, Netflix, Nike... ZB
Transcript : Laboratory Corporation of America Holdings - Analyst/Investor Day CI
HSBC Initiates Laboratory Corp of America With Hold Rating, Price Target is $210 MT
Singapore to expand ocean CO2 removal project as scientists call for more research RE
XLMedia extends reach in North Carolina with content deal for WRAL.com AN
Fortrea's Second-Quarter Earnings Decline; Projects Flat-to-Down 2023 Revenue MT
Wells Fargo Adjusts Price Target on Laboratory Corp of America Holdings to $270 From $290, Maintains Overweight Rating MT
Insider Sell: Laboratory Corp Of America Holdings MT
Laboratory Corp of America Enters Up to $1 Billion Share Repurchase Agreements MT
More news
1 day-0.80%
1 week-4.47%
Current month-0.97%
1 month-2.62%
3 months-4.70%
6 months-13.62%
Current year-15.45%
More quotes
1 week
199.01
Extreme 199.0089
208.73
1 month
198.69
Extreme 198.685
208.73
Current year
198.69
Extreme 198.685
258.90
1 year
198.69
Extreme 198.685
258.90
3 years
189.60
Extreme 189.6
317.17
5 years
98.02
Extreme 98.02
317.17
10 years
87.01
Extreme 87.01
317.17
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 2019
Director of Finance/CFO 62 2014
Chief Tech/Sci/R&D Officer 60 2014
Members of the board TitleAgeSince
Director/Board Member 57 2021
Chairman 59 2020
Director/Board Member 65 2006
More insiders
Date Price Change Volume
23-10-02 197.56 -1.74% 190 502
23-09-29 201.05 -1.09% 1,090,832
23-09-28 203.26 -0.78% 809,340
23-09-27 204.85 -0.25% 757,100
23-09-26 205.36 -1.47% 938,743

Delayed Quote Nyse, October 02, 2023 at 09:41 am EDT

More quotes
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
201.05USD
Average target price
245.85USD
Spread / Average Target
+22.28%
Consensus
  1. Markets
  2. Equities
  3. Stock Laboratory Corporation of America Holdings - Nyse
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer